Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/26 16:15 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Malabre Richard C | MA | O | SVP,Chie | 4 | S.d | -239 | 2.22 | 0 | -108 | 299 | D | |||||||||||||||
2/4/26 16:13 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Grund Nicholas | MA | O | Chief Co | 2 | S.d | -235 | 1.67 | 0 | -140 | 562 | D | |||||||||||||||
2/4/26 16:13 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Burke Steven Keith | MA | O | SVP,Chie | 3 | S.d | -213 | 1.70 | 0 | -125 | 948 | D | |||||||||||||||
2/4/26 16:12 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Rucci Carolyn M. | MA | O | SVP,GC | 1 | S | -97 | 1.39 | 0 | -70 | 588 | D | |||||||||||||||
2/4/26 16:11 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Ostrowski Erik | MA | O | SVP,CFO, | 2 | S | -200 | 2.63 | 0 | -76 | 673 | D | |||||||||||||||
2/4/26 16:10 | 2/2/26 | AKBA | Health | Drug | Pharmaceutical Preparations | Butler John P. | MA | DO | CEO,P | 3 | S.d | -862 | 1.62 | 0 | -532 | 3,458 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |